For histological type, frequency of KRAS mutation was higher in poorly cohesive carcinoma (75%, n = 3/4), than in other histological types (58.8% in mucinous adenocarcinoma, 51.9% in adenocarcinoma NOS). This evidence concerns the gene KRAS and carcinoma.